Type 2 diabetes is a leading cause of death and morbidity and is a health priority in Australia. This randomised controlled trial will explore whether remote access to clinical care, supported by telehealth technologies over high speed broadband, leads to improved diabetes control in a way that benefits patients, carers and clinicians and improves the overall health system. People in the intervention arm of the trial will receive additiol diabetes care from a care coorditor nurse via an in-home broadband communication device that can capture clinical measures, provide regular health assessments and videoconference with other health professiols when required. Patients in the control arm of the trial will receive usual care from their GP and participate in the clinical measurement and quality of life components of the evaluation. The trial evaluation will include biomedical, psychological, self-magement and quality of life measures. Data on utilisation rates and satisfaction with the technology will be collected and cost -effectiveness alyses undertaken. The role of this technology in health care reform will be explored.
Unless otherwise indicated, works by Griffith University Scholars are © Griffith University. For further details please refer to the University Intellectual Property Policy.